Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement

Reginster, J.-Y.; Reiter-Niesert, S.; Bruyère, O.; Berenbaum, F.; Brandi, M.-L.; Branco, J.; Devogelaer, J.-P.; Herrero-Beaumont, G.; Kanis, J.; Maggi, S.; Maheu, E.; Richette, P.; Rizzoli, René; Cooper, C.

doi:10.1016/j.joca.2015.07.001

Scientific article

English

Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement

ContributorsReginster, J.-Y.; Reiter-Niesert, S.; Bruyère, O.; Berenbaum, F.; Brandi, M.-L.; Branco, J.; Devogelaer, J.-P.; Herrero-Beaumont, G.; Kanis, J.; Maggi, S.; Maheu, E.; Richette, P.; Rizzoli, René; Cooper, C.

Published inOsteoarthritis and cartilage, vol. 23, no. 12, p. 2086-2093

Publication date2015

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Génétique des ostéoporoses (544)

Citation (ISO format)

REGINSTER, J.-Y. et al. Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement. In: Osteoarthritis and cartilage, 2015, vol. 23, n° 12, p. 2086–2093. doi: 10.1016/j.joca.2015.07.001

Article (Published version)

Identifiers

PID : unige:78674
DOI : 10.1016/j.joca.2015.07.001
PMID : 26187570

Commercial URLhttp://linkinghub.elsevier.com/retrieve/pii/S1063458415012315

Journal ISSN1063-4584

477views

0downloads

Creation11/12/2015 12:55:00

First validation11/12/2015 12:55:00

Update time15/03/2023 00:58:53

Status update15/03/2023 00:58:52

Last indexation31/10/2024 03:18:44

Archive ouverte UNIGE

Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement

Technical informations